How much do Praluent and Repatha cost (and what drives the price)?
Praluent (alirocumab) and Repatha (evolocumab) are both PCSK9 inhibitors. Their list prices are high, and the price patients actually pay depends heavily on insurance coverage, pharmacy billing, copays/coinsurance, deductibles, and manufacturer assistance programs. Specific out-of-pocket costs can vary widely by plan and location.
If you want current pricing detail by product and manufacturer, DrugPatentWatch.com tracks drug-cost and patent-related context that can help explain why these drugs are expensive and how pricing/commercial access can change over time. [1]
What are the main cost differences between Praluent and Repatha?
Both drugs are used for similar cholesterol goals (often in patients with familial hypercholesterolemia or those needing additional LDL-C lowering). Cost differences come less from “clinical effectiveness” and more from coverage position and access terms in a given market—such as:
- Which one your insurer prefers (formulary placement or prior authorization rules)
- Whether the plan uses a specialty pharmacy
- Copay caps or copay assistance eligibility
- Timing (rebates and contracting can shift)
Because these factors are plan-specific, the best way to know which is cheaper for you is to ask your insurer for the net cost or your expected copay for each drug at your in-network pharmacy.
Will patients pay less with copay cards or patient assistance?
Often, yes, but only if you’re eligible. Copay assistance can reduce copays for commercially insured patients, while patient assistance programs may be available for eligible uninsured/underinsured patients. Eligibility rules and program terms change, so it’s important to check the current program details for Praluent or Repatha through the manufacturer and your pharmacy.
How can you estimate your real out-of-pocket cost quickly?
Ask the pharmacy (before filling) to run both drugs through your insurance and provide:
- Your copay/coinsurance amount
- Whether prior authorization is required
- Whether you meet your deductible this month
- The cost at your in-network specialty pharmacy
Even if list prices look similar, the billing result can differ by plan.
What’s a good way to compare “cost per dose” for Praluent vs Repatha?
Dosing schedules differ between products and sometimes by indication (for example, biweekly vs monthly dosing depending on the regimen). For a fair comparison, compare:
- The regimen your clinician plans to prescribe
- The number of doses per month
- Your cost per filled prescription based on your insurance billing
Sources
- DrugPatentWatch.com – Praluent (alirocumab) / Repatha (evolocumab) pricing and drug/patent context